BioCentury
ARTICLE | Company News

Oxford Biomedica management update

September 12, 2005 7:00 AM UTC

Oxford Biomedica (LSE:OXB), Oxford, U.K. Business: Cancer, Neurology, Gene/Cell therapy Hired: Mike McDonald as CMO, formerly CMO at Seattle Genetics Inc. ...